Manifestations of chronic hepatitis C virus infection beyond the liver

Ira M Jacobson1, Patrice Cacoub, Luigino Dal Maso

  • 1Center for the Study of Hepatitis C, Joan and Sanford I. Weill Medical College of Cornell University, New York, New York 10021, USA. imj2001@med.cornell.edu

Insights

Chronic hepatitis C virus (HCV) infection impacts multiple organ systems beyond the liver, causing serious extrahepatic manifestations. Effective anti-HCV therapy can improve some of these conditions and quality of life.

Area of Science:

  • Hepatology
  • Immunology
  • Infectious Diseases

Background:

  • Chronic hepatitis C virus (HCV) infection is primarily known for liver disease but also significantly affects other organ systems.
  • Extrahepatic manifestations (EHMs) of HCV are diverse, including autoimmune conditions, metabolic disorders, and neurological impairments, reducing patient quality of life.
  • These EHMs increase the complexity and cost of managing HCV infection.

Purpose of the Study:

  • To review the spectrum of extrahepatic manifestations associated with chronic hepatitis C virus infection.
  • To discuss the impact of these manifestations on patient quality of life and disease management.
  • To highlight the role of HCV in the pathogenesis of certain EHMs and the potential benefits of anti-HCV therapy.

Main Methods:

  • Literature review of studies investigating extrahepatic manifestations of hepatitis C virus.
  • Analysis of clinical data on the impact of HCV on various organ systems and quality of life.
  • Evaluation of treatment outcomes for HCV and its associated extrahepatic conditions.

Main Results:

  • HCV infection is linked to mixed cryoglobulinemia vasculitis, lymphoproliferative disorders, renal disease, insulin resistance, type 2 diabetes, sicca syndrome, and rheumatoid arthritis-like polyarthritis.
  • Quality of life is diminished by fatigue, depression, and cognitive impairment in HCV patients.
  • Mixed cryoglobulinemia vasculitis, certain lymphomas, insulin resistance, and cognitive dysfunction show improvement with anti-HCV therapy.

Conclusions:

  • Hepatitis C virus plays a role in the pathogenesis of specific extrahepatic manifestations like mixed cryoglobulinemia vasculitis, certain lymphomas, and insulin resistance.
  • Anti-HCV therapy can positively impact certain extrahepatic manifestations and improve cognitive function and quality of life.
  • Awareness of potential extrahepatic manifestations is crucial for clinicians to effectively manage patients with HCV infection.

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...